🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the producers of acetaminophen, asserting the companies concealed safety concerns that the medication posed to pediatric cognitive development.

The court filing follows thirty days after President Donald Trump promoted an unsubstantiated connection between consuming acetaminophen - alternatively called paracetamol - throughout gestation and autism in offspring.

The attorney general is filing suit against the pharmaceutical giant, which formerly manufactured the medication, the only pain reliever approved for pregnant women, and the current manufacturer, which currently produces it.

In a declaration, he stated they "betrayed America by profiting off of suffering and promoting medication regardless of the dangers."

The company asserts there is no credible evidence linking Tylenol to autism spectrum disorder.

"These companies misled for generations, knowingly endangering millions to boost earnings," Paxton, from the Republican party, declared.

Kenvue said in a statement that it was "seriously troubled by the dissemination of inaccurate information on the security of paracetamol and the potential impact that could have on the health of American women and children."

On its online platform, Kenvue also mentioned it had "consistently assessed the relevant science and there is insufficient valid information that indicates a established connection between using acetaminophen and autism spectrum disorder."

Groups speaking for medical professionals and healthcare providers concur.

ACOG has said paracetamol - the primary component in acetaminophen - is a restricted selection for expectant mothers to treat discomfort and fever, which can pose significant medical dangers if ignored.

"In over twenty years of studies on the consumption of acetaminophen in gestation, no reliable research has successfully concluded that the usage of paracetamol in any period of pregnancy leads to neurological conditions in children," the organization commented.

This legal action mentions latest statements from the previous government in arguing the drug is potentially dangerous.

In recent weeks, Trump raised alarms from medical authorities when he advised expectant mothers to "struggle intensely" not to take acetaminophen when sick.

The FDA then published an announcement that doctors should think about restricting the consumption of Tylenol, while also declaring that "a proven link" between the drug and autism in young ones has not been established.

Health Secretary RFK Jr, who manages the FDA, had vowed in April to undertake "extensive scientific investigation" that would determine the origin of autism in a short period.

But experts cautioned that identifying a single cause of autism - believed by scientists to be the consequence of a complicated interplay of inherited and environmental factors - would not be simple.

Autism is a form of lifelong neurodivergence and disability that influences how persons perceive and engage with the world, and is recognized using physician assessments.

In his court filing, the attorney general - who supports Trump who is running for the Senate - claims the manufacturer and J&J "intentionally overlooked and sought to suppress the science" around acetaminophen and autism spectrum disorder.

The lawsuit attempts to require the firms "destroy any commercial messaging" that claims acetaminophen is secure for expectant mothers.

This legal action mirrors the complaints of a group of guardians of minors with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the makers of Tylenol in 2022.

A federal judge rejected the lawsuit, declaring studies from the plaintiffs' authorities was inconclusive.